Shehzahdi Shebbrin Moonshi

Shehzahdi Shebbrin Moonshi

Auto-generated profile, based on publicly available information

Shehzahdi Shebbrin Moonshi

School of Environment and Science

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2023 in ACS Nano
Verified
Journal Article
Closed access
HAHossein Adelnia
Hossein Adelnia
SMShehzahdi Shebbrin Moonshi
Shehzahdi Shebbrin Moonshi
YWYuao Wu
Yuao Wu
ABAndrew C. Bulmer
Andrew C. Bulmer
RMRyan Mckinnon
Ryan Mckinnon
Hang TaHang Ta
Hang Ta

9 February 2023 in Applied Materials Today
Verified
Journal Article
Open access
NFNajma Annuria Fithri
Najma Annuria Fithri
YWYuao Wu
Yuao Wu
GCGary Cowin
Gary Cowin
FAFahima Akther
Fahima Akther
DTDiem-Huong Nguyen Tran
Diem-Huong Nguyen Tran
Hang TaHang Ta
Hang Ta

21 August 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SMShehzahdi S. Moonshi
Shehzahdi S. Moonshi
KVKarla X. Vazquez-Prada
Karla X. Vazquez-Prada
JTJoyce Tang
Joyce Tang
NHNicholas J. Westra van Holthe
Nicholas J. Westra van Holthe
GCGary Cowin
Gary Cowin
Hang TaHang Ta
Hang Ta

12 May 2025 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
YWYuao Wu
Yuao Wu
SMShehzahdi S. Moonshi
Shehzahdi S. Moonshi
Hang TaHang Ta
Hang Ta

15 October 2021 in WIREs Nanomedicine and Nanobiotechnology
Verified
Journal Article
Closed access
PDF file
SMShehzahdi Shebbrin Moonshi
Shehzahdi Shebbrin Moonshi
YWYuao Wu
Yuao Wu
Hang TaHang Ta
Hang Ta

5 December 2024 in Materials Today Bio
Verified
Journal Article
Open access
JTJoyce L.Y. Tang
Joyce L.Y. Tang
SMShehzahdi S. Moonshi
Shehzahdi S. Moonshi
YWYuao Wu
Yuao Wu
GCGary Cowin
Gary Cowin
KPKarla X. Vazquez- Prada
Karla X. Vazquez- Prada
Hang TaHang Ta
Hang Ta
We explored the feasibility of a self-assembled chitosan nanocomposite incorporating cerium oxide/nanoceria and superparamagnetic iron oxide nanoparticles (Chit−IOCO NPs), conjugated with methotrexate (MTX) and Cy5 dye, as an integrated cancer theranostic nanosystem (Chit-IOCO-MTX-Cy5). In this system, nanoceria serves as an anti-cancer agent, while the superparamagnetic iron oxide nanoparticles function as a negative contrast agent for MR imaging. This dual metal oxide nanocomposite is conjugated with MTX which is a structural analogue of folate, serving both as a targeting mechanism for folate receptors on cancer cells and as a chemotherapeutic drug. Chit−IOCO-MTX-Cy5 exhibited exceptional negative contrast in T2 and T2∗-weighted MRI, achieving a high relaxivity of 409.5 mM⁻1 s⁻1 which is superior to clinically approved agents. The nanocomposite demonstrated both pro-oxidative and antioxidative properties, significantly increasing reactive oxygen species (ROS) production in U87MG cells (1.4-fold change), which triggered apoptosis in these cancer cells. Simultaneously, it exhibited ROS scavenging activity in non-malignant endothelial cells (0.8-fold change). Intravenous infusion of Chit-IOCO-MTX-Cy5 (5 mg/kg MTX) led to significant tumor growth inhibition, indicating a synergistic enhancement of anti-cancer effects when combining MTX and nanoceria, compared to free MTX or nanoceria without MTX conjugation. Importantly, after treatment cessation, tumours in the nanocomposite group did not re-grow, while those in the free MTX group rapidly did. In vivo MR and fluorescence imaging revealed improved uptake and retention of Chit−IOCO-MTX-Cy5 in tumours compared to nanoceria without MTX. Notably, biosafety and biochemical analyses in mice showed no significant differences between the Chit−IOCO-MTX-Cy5 treatment group and control groups.